Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163245 | SCV000213772 | likely benign | Hereditary cancer-predisposing syndrome | 2016-09-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV004562336 | SCV000282721 | likely benign | Familial adenomatous polyposis 1 | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000228768 | SCV000516565 | likely benign | not provided | 2019-04-17 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 15656904) |
Color Diagnostics, |
RCV000163245 | SCV000681543 | likely benign | Hereditary cancer-predisposing syndrome | 2017-01-25 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000228768 | SCV001133314 | likely benign | not provided | 2019-05-31 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003995242 | SCV004839704 | likely benign | Classic or attenuated familial adenomatous polyposis | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004562336 | SCV004932918 | benign | Familial adenomatous polyposis 1 | 2024-03-14 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |